Please assess the completion status of the following clinical trial:

Trial Title: Mindfulness and Cognition in Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* DSM-IV diagnosis of schizophrenia (men only)~* aged 18-55~* with no change in antipsychotic medication and clinical status within four weeks prior to the study~* affiliates or entitled to a social security scheme~* who have given their informed consent before participating in the study.~Exclusion Criteria:~* History of head trauma, neurological disease or not stabilized serious physical illness~* Disorders related to the use of a psychoactive substance, as defined by the DSM-IV (abuse, dependence or withdrawal) within 6 months~* Beta blocking and anti-arrhythmic medications.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Mindfulness (Type: EXPERIMENTAL): Patient will have 8 sessions (1h30) of mindfulness based on Kabat-Zinn program during one month.
- Control (Type: NO_INTERVENTION): Patient will have usual medical care.

Based on this trial design, predict the completion outcome and termination type (if applicable).